Zoetis (NY:ZTS)

69.69 +0.59 (+0.85%)

Official Closing Price Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Zoetis

< Previous 1 2

...

23 24 25 26 27 28 29 30 Next >

Zoetis Earnings Perspective: Return On Invested Capital ↗

May 24, 2022

According to Benzinga Pro, during Q1, Zoetis (NYSE:ZTS) earned $594.00 million, a 43.83% increase from the preceding quarter. Zoetis also posted a total of $1.99 billion in sales, a 0.97% increase...

Via Benzinga

Zoetis Declares Third Quarter 2022 Dividend

May 19, 2022

From Zoetis Inc.

Via Business Wire

7 Defensive Dividend Healthcare Stocks to Buy Now ↗

May 06, 2022

As market conditions remain rocky, adding high-quality healthcare stocks to your portfolio may be a great way to play defense.

Via InvestorPlace

Zoetis Delivers First-Quarter Beat, But Guidance Takes An Unexpected Hit ↗

May 05, 2022

Zoetis posted a strong earnings number Thursday, but the guidance haircut was unexpected.

Via Investor's Business Daily

Zoetis: Q1 Earnings Insights ↗

May 05, 2022

Zoetis (NYSE:ZTS) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Zoetis beat estimated earnings by 7.32%,...

Via Benzinga

Zoetis: Q4 Earnings Insights ↗

February 15, 2022

Zoetis (NYSE:ZTS) reported its Q4 earnings results on Tuesday, February 15, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Zoetis Announces First Quarter 2022 Results

May 05, 2022

From Zoetis Inc.

Via Business Wire

Earnings Scheduled For May 5, 2022 ↗

May 05, 2022

Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.

Via Benzinga

CNBC's Final Trades: Zoetis, VanEck Gold Miners ETF, Paramount Global And This Energy Stock ↗

May 03, 2022

On CNBC’s “Halftime Report Final Trades,” Brenda Vingiello of Sand Hill Global Advisors said Zoetis Inc (NYSE: ZTS) is “the largest provider of vaccines and medicines for pets and live

Via Benzinga

Why Stephanie Link Is Watching Starbucks And This Stock Down Nearly 30% YTD ↗

May 02, 2022

Hightower Advisors' Stephanie Link believes we are still in the midst of a bull market. Accordingly, she has identified a couple of stocks well off their highs that she would like to buy on any further...

Via Benzinga

Zoetis Foundation Announces First Round of 2022 Grants to Advance Farmer and Veterinarian Education, Livelihoods and Wellness

April 12, 2022

From Zoetis Inc.

Via Business Wire

Blue-Chip Pharma Stock Among Best to Own This Quarter ↗

April 06, 2022

With the second quarter currently underway, traders have the chance to revisit their portfolios and make any necessary adjustments.

Via Talk Markets

Zoetis to Host Webcast and Conference Call on First Quarter 2022 Financial Results

March 31, 2022

From Zoetis Inc.

Via Business Wire

The New 'Return On Character' ETF Doesn't Include Musk Or Zuckerberg: Who Made The Cut? ↗

March 25, 2022

A new active ETF launched this week with a unique spin on how it picks the companies to include in the fund. What Happened: ROC I...

Via Benzinga

3 Beaten-Down Growth Stocks With More Than 50% Upside Potential ↗

February 25, 2022

The key to picking growth stocks right now is to look for companies whose earnings momentum and growth can withstand any market conditions.

Via InvestorPlace

Zoetis to Participate in the Bank of America Securities 2022 Animal Health Summit

February 22, 2022

From Zoetis Inc.

Via Business Wire

Zoetis's Return On Capital Employed Insights ↗

February 16, 2022

Pulled from Benzinga Pro data, Zoetis (NYSE:ZTS) posted Q4 earnings of $413.00 million, an increase from Q3 of 25.18%. Sales dropped to $1.97 billion, a 1.16% decrease between quarters.

Via Benzinga

4 Top Stock Trades for Wednesday: NVDA, SPCE, ABNB, ZTS ↗

February 15, 2022

Nvidia, Virgin Galactic, Airbnb and Zoetis were our top stock trades for Wednesday. Here's how the charts are setting up right now.

Via InvestorPlace

Zoetis Tops Quarterly Forecasts As Spot And Fluffy Contribute To Sales Growth ↗

February 15, 2022

Companion animal sales continued their lead with livestock sales falling again.

Via Investor's Business Daily

Zoetis Q4 Sales Cushioned By Higher Companion Animal Product Sales, Issues FY22 Outlook ↗

February 15, 2022

Zoetis Inc (NYSE: ZTS) has reported Q4 FY21 revenue of $2 b

Via Benzinga

Zoetis Q4 Sales Cushioned By Higher Companion Animal Product Sales, Issues FY22 Outlook ↗

February 15, 2022

Zoetis Inc. has reported Q4 FY21 revenue of $2 billion, an increase of 9% Y/Y, beating the consensus of $1.93 billion.

Via Talk Markets

Zoetis Reports Fourth Quarter and Full Year 2021 Results

February 15, 2022

From Zoetis Inc.

Via Business Wire

Earnings Scheduled For February 15, 2022 ↗

February 15, 2022

Companies Reporting Before The Bell • FirstService (NASDAQ:FSV) is estimated to report quarterly earnings at $1.31 per share on revenue of $1.07 billion.

Via Benzinga

Earnings Outlook For Zoetis ↗

February 14, 2022

Zoetis (NYSE:ZTS) is set to give its latest quarterly earnings report on Tuesday, 2022-02-15. Here's what investors need to know before the announcement. Analysts estimate that Zoetis will report an...

Via Benzinga

Zoetis Declares Second Quarter 2022 Dividend

February 08, 2022

From Zoetis Inc.

Via Business Wire

10 Health Care Stocks Whale Activity In Today's Session ↗

January 20, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our...

Via Benzinga

7 of the Top-Rated Pharmaceutical Stocks for Q1 ↗

January 18, 2022

As the market begins to shift from high-growth, tech-fueled start-ups, one good long-term growth option is quality pharmaceutical stocks.

Via InvestorPlace

Zoetis's Ex-Dividend Date Is Tuesday, Here's What You Need To Know ↗

January 14, 2022

Tuesday marks the last chance for investors to receive the next dividend payout from Zoetis. What's Happening (NYSE:

Via Benzinga

FDA Approves Zoetis' Solensia To Control Osteoarthritis Pain In Cats ↗

January 14, 2022

The FDA has approved Zoetis Inc's (NYSE: ZTS) Solensia (frunevetmab injection) to control the pain of osteoarthritis (OA) in cats, helping improve their...

Via Benzinga

Zoetis Announces FDA Approval of Solensia™ (frunevetmab injection) to Control Osteoarthritis Pain in Cats

January 13, 2022

From Zoetis Inc.

Via Business Wire

< Previous 1 2

...

23 24 25 26 27 28 29 30 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.